Flock Feed Overlaps Watchlist Portfolio Insider Calendar Search Account

Feed
Overlap
Watch
Folio
Insider
Cal
Search
Me

Flock — Smart-money disclosures, made readable

An2 Therapeutics Inc

ANTXNASDAQ · US

Sign in for alerts Sign in to add to portfolio

Holders

Renaissance Technologies
13F filer
$679.9K
198,800 sh
as-of 31 Mar 2026Quarterly
BlackRock
13F filer
$644.4K
299,703 sh
as-of 30 Jun 2024Stale

Ownership

Ownership data not yet available for this security.

Disclosure timeline

REDUCEDT+7
Readnour Robin Shane
An2 Therapeutics Inc · NASDAQ
−18,706 sh · $112.4K
Filed 19 Aug 2026SEC Form 4view source
REDUCEDT+7
Readnour Robin Shane
An2 Therapeutics Inc · NASDAQ
−16,696 sh · $100.3K
Filed 19 Aug 2026SEC Form 4view source
DISCLOSEDQuarterly
Renaissance Technologies
An2 Therapeutics Inc · NASDAQ
198,800 sh · $679.9K
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
BlackRock
An2 Therapeutics Inc · NASDAQ
299,703 sh · $644.4K
Filed 30 Jun 2024SEC 13Fview source

Announcements

No announcements on record for this security.

ANTXNASDAQ · US

Sign in for alerts Sign in to add to portfolio

Latest filing19 Aug 2026T+7

2 disclosed holders · 4 disclosures · 0 announcements

Ownership

Ownership data not yet available for this security.

Announcements

No announcements on record for this security.